Inhibition of intraerythrocytic development of Plasmodium falciparum by proteinase inhibitors
- 1 January 1990
- journal article
- Published by Wiley in FEBS Letters
- Vol. 259 (2) , 257-259
- https://doi.org/10.1016/0014-5793(90)80022-b
Abstract
A group of inactivators of cysteinyl proteinases which function by covalent bond formation have been examined for their ability to inhibit thedevelopment of Plasmodium falciparum within red blood cells. The most effective of these caused inactivation of the parasite near 10−8 M concentration. The range of inhibitory action varied with peptide structure in a manner characteristic of affinity labels for proteinases suggesting that the target of inhibition was an unidentified proteinase, probably of the cysteinyl type, but different from cathepsins B and L.Keywords
This publication has 22 references indexed in Scilit:
- Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite developmentMolecular and Biochemical Parasitology, 1989
- Purification and identification of a neutral endopeptidase inPlasmodium falciparum schizonts and merozoitesZeitschrift Fur Parasitenkunde-Parasitology Research, 1989
- A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.Journal of Clinical Investigation, 1988
- Induction of the proteolytic activity of a membrane protein in Plasmodium falciparum by phosphatidyl inositol-specific phospholipase CNature, 1988
- Active center differences between cathepsins L and B: The S1 binding regionFEBS Letters, 1988
- Identification of three stage-specific proteinases of Plasmodium falciparum.The Journal of Experimental Medicine, 1987
- Synthesis of peptide fluoromethyl ketones and the inhibition of human cathepsin BAnalytical Biochemistry, 1985
- Diazomethyl ketone substrate derivatives as active-site-directed inhibitors of thiol proteases. PapainBiochemistry, 1977
- Human Malaria Parasites in Continuous CultureScience, 1976
- On the active site of proteases. III. Mapping the active site of papain; specific peptide inhibitors of papainBiochemical and Biophysical Research Communications, 1968